Sangamo Biosciences reported $-45261000 in EBIT for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Alnylam Pharmaceuticals ALNY:US $ -146732000 47.83M
Amgen AMGN:US $ 2500M 196M
Avrobio Inc AVRO:US $ -29418000 1.46M
Bayer BAYN:GR 4.17B 704M
Biocryst Pharmaceuticals BCRX:US $ -49957000 2.22M
Biogen BIIB:US $ 531.5M 11.7M
Biomarin Pharmaceutical BMRN:US $ 29.33M 95.21M
Bluebird Bio BLUE:US $ -120346000 138.95M
Gilead Sciences GILD:US $ 2897M 1957M
GlaxoSmithKline GSK:LN 2.42B 724M
Intercept Pharmaceuticals ICPT:US $ -10272000 10.59M
IONIS PHARMACEUT IONS:US $ -57504000 278.11M
Johnson & Johnson JNJ:US $ 7540M 1623M
Karyopharm Therapeutics KPTI:US $ -34586000 81.55M
Merk MRK:US $ 5059M 207M
Novartis NOVN:VX 3.15B 266M
Omeros OMER:US $ -35046000 65.69M
Pfizer PFE:US $ 9995M 4136M
Regulus Therapeutics RGLS:US $ -6569000 391K
Sangamo Biosciences SGMO:US $ -45261000 5.36M
Sarepta Therapeutics SRPT:US $ -86881000 18.93M
Ultragenyx Pharmaceutical RARE:US $ -136632000 34.07M
Vertex Pharmaceuticals VRTX:US $ 1033.4M 157.68M
Ziopharm Oncology ZIOP:US $ -9085000 1.23M